Keep in mind the United States Patent Office is a government run entity. Therefore by association, it is going to be filled with bureaucracy, red tape, etc. Patent application examiners are over worked and many times don't understand the technology of patent apps that come across their desks. By self admission, the USPTO is broken and in need of massive reform.
I would imagine that any biotech company in the cardiac field would find their IP attractive. Depends on what the NWCI creditors, whom now appear to be in control of NC's assets, think they are worth. Even then, how much would shareholders see if there was a sale? We are in need of a miracle.
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM